{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:28Z","timestamp":1792788388971,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences","award":["2024GLLH0366"],"award-info":[{"award-number":["2024GLLH0366"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor cells rely on enhanced glycolytic capacity to facilitate cell growth and progression. However, the molecular mechanisms governing glycolysis in triple-negative breast cancer (TNBC) remain largely elusive. In this study, we elucidate the role of OTUB2 in regulating glycolysis in TNBC and delve into the mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized The Cancer Genome Atlas (TCGA) dataset to analyze the expressions of OTUB2, EIF4A3, and TPI1 in breast cancer tissues and specifically in triple-negative breast cancer (TNBC) tissues. qPCR and western blot experiments were performed to confirm the protein expressions of OTUB2, EIF4A3, and TPI1 in TNBC tissues and cell lines. Subsequently, overexpression and knockdown experiments followed by cell functional assays were conducted to elucidate the impact of OTUB2 on EIF4A3\/TPI1-mediated TNBC malignant progression and related molecular mechanisms. Finally, a xenograft mouse model was established to verify the effect of OTUB2 in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TCGA database indicated highly expressions of OTUB2, EIF4A3, and TPI1 in breast cancer tissues and TNBC tissues. Consistently, the mRNA and protein expressions of OTUB2, EIF4A3, and TPI1 were increased in TNBC tissues and cell lines, as compared to para-carcinoma tissues and MCF10A cells. OTUB2 knockdown inhibited cell proliferation, migration and invasion, and decreased glucose uptake, ATP level, lactate production, and ECAR, while the OTUB2 overexpression exhibited the opposite trends. Further data elucidated that OTUB2 stabilized the EIF4A3 protein via deubiquitination, and EIF4A3 interacted with TPI1 to stabilize its mRNA. Overexpression of EIF4A3 exacerbated TNBC malignant activities and glycolysis, while silencing TPI1 reversed these effects. In vivo, the knockdown of OTUB2 significantly inhibited tumor growth in a xenograft mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We conclude that OTUB2 deubiquitinates and stabilizes EIF4A3 to promote TNBC progression via TPI1-mediated glycolysis of tumor cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02260-5","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:35:13Z","timestamp":1773927313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deubiquitination and stabilization of EIF4A3 by OTUB2 contributes to TPI1-mediated glycolysis and TNBC progression"],"prefix":"10.1186","volume":"28","author":[{"given":"Zhiyong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"1130","key":"2260_CR1","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):20211033.","journal-title":"Br J Radiol"},{"issue":"4","key":"2260_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/jcm12041524","volume":"12","author":"J Lee","year":"2023","unstructured":"Lee J. Current treatment landscape for early triple-negative breast cancer (TNBC). J Clin Med. 2023;12(4):1524.","journal-title":"J Clin Med"},{"issue":"2","key":"2260_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.25122\/jml-2021-0108","volume":"15","author":"A Baranova","year":"2022","unstructured":"Baranova A, Krasnoselskyi M, Starikov V, Kartashov S, Zhulkevych I, Vlasenko V, Oleshko K, Bilodid O, Sadchikova M, Vinnyk Y. Triple-negative breast cancer: current treatment strategies and factors of negative prognosis. J Med Life. 2022;15(2):153\u201361.","journal-title":"J Med Life"},{"issue":"1","key":"2260_CR4","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/s41467-022-30376-7","volume":"13","author":"F Trulsson","year":"2022","unstructured":"Trulsson F, Akimov V, Robu M, van Overbeek N, Berrocal DAP, Shah RG, Cox J, Shah GM, Blagoev B, Vertegaal ACO. Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates. Nat Commun. 2022;13(1):2736.","journal-title":"Nat Commun"},{"issue":"20","key":"2260_CR5","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1074\/jbc.RA120.013073","volume":"295","author":"D Sivakumar","year":"2020","unstructured":"Sivakumar D, Kumar V, Naumann M, Stein M. Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases. J Biol Chem. 2020;295(20):6972\u201382.","journal-title":"J Biol Chem"},{"issue":"19","key":"2260_CR6","doi-asserted-by":"publisher","first-page":"e2315348121","DOI":"10.1073\/pnas.2315348121","volume":"121","author":"Y Nan","year":"2024","unstructured":"Nan Y, Wu X, Luo Q, Chang W, Zhao P, Zhang L, Liu Z. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proc Natl Acad Sci U S A. 2024;121(19):e2315348121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"2260_CR7","first-page":"11553","volume":"16","author":"Y Deng","year":"2024","unstructured":"Deng Y, Li J, He Y, Du D, Hu Z, Zhang C, Rao Q, Xu Y, Wang J, Xu K. The deubiquitinating enzymes-related signature predicts the prognosis and immunotherapy response in breast cancer. Aging. 2024;16(15):11553\u201367.","journal-title":"Aging"},{"issue":"1","key":"2260_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/thno.29545","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L, Geng Q, Pan H, Yan M, Yao M. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT\/mTOR signaling pathway in non-small cell lung cancer. Theranostics. 2019;9(1):179\u201395.","journal-title":"Theranostics"},{"issue":"2","key":"2260_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/cbin.11950","volume":"47","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhang J, Yao A, Tian X, Han Z, Yuan Y, Tao K, Yang X. OTUB2 promotes the progression of endometrial cancer by regulating the PKM2-mediated PI3K\/AKT signaling pathway. Cell Biol Int. 2023;47(2):428\u201338.","journal-title":"Cell Biol Int"},{"issue":"6","key":"2260_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/kjm2.12187","volume":"36","author":"ZL Gu","year":"2020","unstructured":"Gu ZL, Huang J, Zhen LL. Knockdown of otubain 2 inhibits liver cancer cell growth by suppressing NF-kappaB signaling. Kaohsiung J Med Sci. 2020;36(6):399\u2013404.","journal-title":"Kaohsiung J Med Sci"},{"issue":"11","key":"2260_CR11","doi-asserted-by":"publisher","first-page":"8199","DOI":"10.1002\/jcp.29475","volume":"235","author":"L Zhang","year":"2020","unstructured":"Zhang L, Chen Y, Bao C, Zhang X, Li H. Eukaryotic initiation Factor 4AIII facilitates hepatocellular carcinoma cell proliferation, migration, and epithelial-mesenchymal transition process via antagonistically binding to WD repeat domain 66 with miRNA-2113. J Cell Physiol. 2020;235(11):8199\u2013209.","journal-title":"J Cell Physiol"},{"key":"2260_CR12","first-page":"1","volume":"43","author":"S Kulavi","year":"2024","unstructured":"Kulavi S, Dhar D, Kamal IM, Chakrabarti S, Bandyopadhyay J. EIF4A3 targeted therapeutic intervention in glioblastoma multiforme using phytochemicals from Indian medicinal plants - an integration of phytotherapy into precision onco-medicine. J Biomol Struct Dyn. 2024;43:1\u201321.","journal-title":"J Biomol Struct Dyn"},{"key":"2260_CR13","doi-asserted-by":"publisher","first-page":"121745","DOI":"10.1016\/j.lfs.2023.121745","volume":"324","author":"X Huang","year":"2023","unstructured":"Huang X, Tan W, Liu Z, Fu X, Li Z, Lai S, Li Q, Zhong X, Qu F, Zhang H, et al. EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647\/FASN axis. Life Sci. 2023;324:121745.","journal-title":"Life Sci"},{"key":"2260_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.omtn.2019.11.017","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Ren S, Xia J, Wei Y, Xi Y. EIF4A3-Induced circ-BNIP3 Aggravated Hypoxia-Induced Injury of H9c2 Cells by Targeting miR-27a-3p\/BNIP3. Mol Ther Nucleic Acids. 2020;19:533\u201345.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"2260_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-022-04655-6","volume":"13","author":"P Liu","year":"2022","unstructured":"Liu P, Sun SJ, Ai YJ, Feng X, Zheng YM, Gao Y, Zhang JY, Zhang L, Sun YP, Xiong Y, et al. Elevated nuclear localization of glycolytic enzyme TPI1 promotes lung adenocarcinoma and enhances chemoresistance. Cell Death Dis. 2022;13(3):205.","journal-title":"Cell Death Dis"},{"issue":"8","key":"2260_CR16","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.cmet.2024.07.008","volume":"36","author":"C Mo","year":"2024","unstructured":"Mo C, Li H, Yan M, Xu S, Wu J, Li J, Yang X, Li Y, Yang J, Su X, et al. Dopaminylation of endothelial TPI1 suppresses ferroptotic angiocrine signals to promote lung regeneration over fibrosis. Cell Metab. 2024;36(8):1839\u201357. e1812.","journal-title":"Cell Metab"},{"issue":"1","key":"2260_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-022-03370-2","volume":"20","author":"X Jin","year":"2022","unstructured":"Jin X, Wang D, Lei M, Guo Y, Cui Y, Chen F, Sun W, Chen X. TPI1 activates the PI3K\/AKT\/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5. J Transl Med. 2022;20(1):191.","journal-title":"J Transl Med"},{"issue":"1","key":"2260_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13287-021-02394-7","volume":"12","author":"H Ni","year":"2021","unstructured":"Ni H, Qin H, Sun C, Liu Y, Ruan G, Guo Q, Xi T, Xing Y, Zheng L. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther. 2021;12(1):325.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2260_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12943-020-01190-w","volume":"19","author":"C Shen","year":"2020","unstructured":"Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, Zhang X, Cao Y, Ma D, Zhu X, et al. m(6)A-dependent glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19(1):72.","journal-title":"Mol Cancer"},{"issue":"1","key":"2260_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-022-02252-1","volume":"41","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liu L, Xia L, Wu N, Wang Y, Li H, Chen X, Zhang X, Liu Z, Zhu M, et al. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1alpha degradation. J Exp Clin Cancer Res. 2022;41(1):44.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2260_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-022-00839-3","volume":"8","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, Zeng Z, Liu Z, Zhang Z, Sun J, Wang X, Ma M, Ye X, Yu J, Kang W. OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer. Cell Death Discov. 2022;8(1):45.","journal-title":"Cell Death Discov"},{"issue":"4","key":"2260_CR22","doi-asserted-by":"publisher","first-page":"111561","DOI":"10.1016\/j.celrep.2022.111561","volume":"41","author":"W Chang","year":"2022","unstructured":"Chang W, Luo Q, Wu X, Nan Y, Zhao P, Zhang L, Luo A, Jiao W, Zhu Q, Fu Y, et al. OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis. Cell Rep. 2022;41(4):111561.","journal-title":"Cell Rep"},{"issue":"4","key":"2260_CR23","doi-asserted-by":"publisher","first-page":"e4020","DOI":"10.1002\/cbf.4020","volume":"42","author":"C Guo","year":"2024","unstructured":"Guo C, Zhang M, Jin X, Zhu C, Qian J, Tao M. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p\/OTUB2 axis. Cell Biochem Funct. 2024;42(4):e4020.","journal-title":"Cell Biochem Funct"},{"issue":"10","key":"2260_CR24","first-page":"e1886","volume":"6","author":"E Aikio","year":"2023","unstructured":"Aikio E, Koivukoski S, Kallio E, Sadeesh N, Niskanen EA, Latonen L. Complementary analysis of proteome-wide proteomics reveals changes in RNA binding protein-profiles during prostate cancer progression. Cancer Rep (Hoboken). 2023;6(10):e1886.","journal-title":"Cancer Rep (Hoboken)"},{"key":"2260_CR25","doi-asserted-by":"publisher","first-page":"110690","DOI":"10.1016\/j.cellsig.2023.110690","volume":"108","author":"P Luo","year":"2023","unstructured":"Luo P, Gong Y, Weng J, Wen F, Luo J, Hu C, Xiao J, Shu J. CircKIF4A combines EIF4A3 to stabilize SDC1 expression to activate c-src\/FAK and promotes TNBC progression. Cell Signal. 2023;108:110690.","journal-title":"Cell Signal"},{"issue":"5","key":"2260_CR26","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1002\/tox.24171","volume":"39","author":"B Zheng","year":"2024","unstructured":"Zheng B, Zhou B, Ye D, Wang Y, Zheng W, Wang X, Liu D, Qian F, Zhou X, Yan T, et al. LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated beta-catenin mRNA nuclear exportation. Environ Toxicol. 2024;39(5):3026\u201339.","journal-title":"Environ Toxicol"},{"issue":"3","key":"2260_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H, Wei H, Wang H, Wang Z, Li J, Ou Y, Xiao X, Wang W, Chang A, Sun W, et al. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis. 2022;13(3):206.","journal-title":"Cell Death Dis"},{"issue":"2","key":"2260_CR28","doi-asserted-by":"publisher","first-page":"e1583","DOI":"10.1002\/ctm2.1583","volume":"14","author":"Y Yu","year":"2024","unstructured":"Yu Y, Deng H, Wang W, Xiao S, Zheng R, Lv L, Wang H, Chen J, Zhang B. LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m(6) A modification in triple-negative breast cancer. Clin Transl Med. 2024;14(2):e1583.","journal-title":"Clin Transl Med"},{"key":"2260_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s44321-025-00206-6","volume":"17","author":"F Mei","year":"2024","unstructured":"Mei F, Deng D, Cao Z, Lou L, Chen K, Hu M, Zhu Z, Shen J, Zhang J, Liang J, et al. Deubiquitination of RIPK3 by OTUB2 potentiates neuronal necroptosis after ischemic stroke. EMBO Mol Med. 2024;17:679.","journal-title":"EMBO Mol Med"},{"issue":"14","key":"2260_CR30","doi-asserted-by":"publisher","first-page":"e18465","DOI":"10.1111\/jcmm.18465","volume":"28","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li W, Wang Z, Yang Q, Chen L, Chen W, Qu X. EIF4A3-Induced CircDHTKD1 regulates glycolysis in non-small cell lung cancer via stabilizing PFKL. J Cell Mol Med. 2024;28(14):e18465.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2260_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-024-02052-5","volume":"23","author":"X Jiang","year":"2024","unstructured":"Jiang X, Peng M, Liu Q, Peng Q, Oyang L, Li S, Xu X, Shen M, Wang J, Li H, et al. Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation. Mol Cancer. 2024;23(1):151.","journal-title":"Mol Cancer"},{"issue":"11","key":"2260_CR32","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00109-024-02486-w","volume":"102","author":"Y Lin","year":"2024","unstructured":"Lin Y, Kong L, Zhao Y, Zhai F, Zhan Z, Li Y, Jingfei Z, Chunhong Y, Jin X. The oncogenic role of EIF4A3\/CDC20 axis in the endometrial cancer. J Mol Med (Berl). 2024;102(11):1395\u2013410.","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"2260_CR33","doi-asserted-by":"publisher","first-page":"e22909","DOI":"10.1002\/jbt.22909","volume":"35","author":"Q Liu","year":"2021","unstructured":"Liu Q, Dong H. EIF4A3-mediated hsa_circ_0088088 promotes the carcinogenesis of breast cancer by sponging miR-135-5p. J Biochem Mol Toxicol. 2021;35(11):e22909.","journal-title":"J Biochem Mol Toxicol"},{"issue":"9","key":"2260_CR34","first-page":"4361","volume":"12","author":"J Xia","year":"2022","unstructured":"Xia J, Wu C, Tang Y, Tang J, Zhu D, Zhang F, Xu Z, Sun D, Tan Z, Zhuo H. CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner. Am J Cancer Res. 2022;12(9):4361\u201372.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2260_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s11658-022-00386-w","volume":"27","author":"L Ren","year":"2022","unstructured":"Ren L, Fang X, Shrestha SM, Ji Q, Ye H, Liang Y, Liu Y, Feng Y, Dong J, Shi R. LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability. Cell Mol Biol Lett. 2022;27(1):89.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"2260_CR36","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Li J, Zhao G, Huang KC, Cardenas H, Wang Y, Matei D, Cheng JX. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun. 2022;13(1):4554.","journal-title":"Nat Commun"},{"issue":"4","key":"2260_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/1759-7714.15196","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Pan B, Zhang F, Jia X, Zhu X, Tong X, Zhao J, Li C. TPI1 promotes MAPK\/ERK-induced EMT, cell migration and invasion in lung adenocarcinoma. Thorac Cancer. 2024;15(4):327\u201338.","journal-title":"Thorac Cancer"},{"issue":"3","key":"2260_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/ptr.7661","volume":"37","author":"H Xu","year":"2023","unstructured":"Xu H, Li L, Qu L, Tu J, Sun X, Liu X, Xu K. Atractylenolide-1 affects glycolysis\/gluconeogenesis by downregulating the expression of TPI1 and GPI to inhibit the proliferation and invasion of human triple-negative breast cancer cells. Phytother Res. 2023;37(3):820\u201333.","journal-title":"Phytother Res"},{"issue":"1","key":"2260_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","volume":"19","author":"X Zheng","year":"2020","unstructured":"Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R, Zhang L, Chen J. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19(1):73.","journal-title":"Mol Cancer"},{"issue":"1","key":"2260_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41420-022-00892-y","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang X, Song H, Fang L, Wu T. EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K\/AKT signaling pathway. Cell Death Discov. 2022;8(1):92.","journal-title":"Cell Death Discov"},{"key":"2260_CR41","doi-asserted-by":"publisher","first-page":"107695","DOI":"10.1016\/j.phrs.2025.107695","volume":"215","author":"C Wang","year":"2025","unstructured":"Wang C, Wan S, Li K, Chen S, Shu Y, Liu S, Yang L. TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation. Pharmacol Res. 2025;215:107695.","journal-title":"Pharmacol Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02260-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02260-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:30:05Z","timestamp":1781641805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02260-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2260"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02260-5","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior information and written consent were secured from all participants prior to initiating the study. This research was granted approval by the Ethics Committee of Tianjin Medical University Cancer Institute and Hospital (approval no.8247311).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}